AzureCell is a Swiss regenerative cell therapy company born from two decades of pioneering neuroscience and cell-engineering research at the University of Geneva.
We are scientists and innovators united by a shared belief: longevity is not just living longer, but living fully. To live fully, we must defeat neurodegenerative brain diseases that still have no cure and deprive millions of their independence, identity and quality of life.
We believe that a fearless future free from neurodegenerative disease is within reach, and we are unlocking this future by pioneering the next-generation of regenerative cell therapies for the brain.
16.05.2025
Eight Venture Kick alumni among finalists for De Vigier Award 2025 (venturekick.ch)
11.04.2025
Tech innovators of tomorrow face off at Startup Champions Seed Night 2025 (venturelab.swiss)
10.02.2025
AIT India-Swiss Camp 2024/25: Sciencepreneurs discover the Swiss Innovation Ecosystem (venturelab.swiss)
25.11.2024
Academia-Industry Training India 2024: Strengthening Swiss-Indian innovation ties (venturelab.swiss)
17.12.2025
Kickfund CLA
15.12.2025
09.12.2025
First Business Angel Investment
09.07.2025
Venture Kick Stage 3
16.05.2025
No Jobs
Youtube
Venture Kick supports potential entrepreneurs with start capital up to CHF 150'000 as well as hands-on execution support and access to a nationwide network of investors and experts in the startup field. Multiple times per year, 8 selected projects get the opportunity to present their business ideas in front of a panel. The 5 most promising projects enter the support process. After 9 months at the latest, the startups incorporate and enter the market. Since 2007, Venture Kick has invested over CHF 58 million in over 1111 projects.
Website:
www.azurecell.co
Headquarter:
Geneva
Foundation Date:
September 2025
Technology:
Sectors: